Last reviewed · How we verify
Nevirapine, Efavirenz
Nevirapine, Efavirenz is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration. It is currently in Phase 2 development.
At a glance
| Generic name | Nevirapine, Efavirenz |
|---|---|
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy (PHASE3)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (PHASE2, PHASE3)
- Research on the Psychological Status of Patients With HIV-1 Infection
- Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen (PHASE2, PHASE3)
- A Prospective Cohort of Children With HIV Infection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nevirapine, Efavirenz CI brief — competitive landscape report
- Nevirapine, Efavirenz updates RSS · CI watch RSS
- The HIV Netherlands Australia Thailand Research Collaboration portfolio CI
Frequently asked questions about Nevirapine, Efavirenz
What is Nevirapine, Efavirenz?
Nevirapine, Efavirenz is a Small molecule drug developed by The HIV Netherlands Australia Thailand Research Collaboration.
Who makes Nevirapine, Efavirenz?
Nevirapine, Efavirenz is developed by The HIV Netherlands Australia Thailand Research Collaboration (see full The HIV Netherlands Australia Thailand Research Collaboration pipeline at /company/the-hiv-netherlands-australia-thailand-research-collaboration).
What development phase is Nevirapine, Efavirenz in?
Nevirapine, Efavirenz is in Phase 2.